Advancing heart failure care through clinical trials + outcomes research
At Tufts Medical Center, our team has been at the forefront of advanced heart failure clinical trials and device research. We were a high enroller in the Medtronic HVAD trial and the first center in New England to implant the Evaheart 2 LVAD. We’re preparing to join the upcoming BrioVAD clinical trial and continue to lead nationally through our founding role in the Cardiogenic Shock Working Group—an international collaborative focused on advancing diagnosis, treatment, and outcomes for cardiogenic shock.
Our faculty also lead and contribute to a wide range of investigator-initiated and industry-sponsored trials. We maintain a robust transplant and LVAD database that supports ongoing quality improvement and clinical research.
At Beth Israel Deaconess Medical Center, heart failure specialists are advancing ECMO management and hold leadership roles within the Cardiogenic Shock Working Group. In partnership with interventional cardiologists, they participate in numerous trials of novel device-based therapies for heart failure, including transcatheter valve replacement and percutaneous ventricular remodeling.
Beth Israel Deaconess Medical Center is also home to the nationally recognized Smith Center for Outcomes Research, which conducts influential population health research using large datasets to help shape the future of cardiovascular care.
